2011
DOI: 10.2460/javma.239.11.1463
|View full text |Cite
|
Sign up to set email alerts
|

Phenylpropanolamine toxicosis in dogs: 170 cases (2004–2009)

Abstract: Results suggested that with supportive care, the prognosis for dogs that had ingested an overdose of phenylpropanolamine was excellent.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 38 publications
0
1
0
Order By: Relevance
“…Hypertension is a widely recognized adverse effect of α‐agonist use in humans. It has been reported with PPA treatment in dogs at a much lower rate, but preexisting hypertension or comorbidities that predispose to hypertension such as kidney disease or hyperthyroidism are considered contraindications for its use . Reevaluation of blood pressure during treatment with PPA is recommended to monitor for hypertension, particularly because USMI patients are likely to be on lifelong treatment, often with dose escalation over time.…”
Section: Discussionmentioning
confidence: 99%
“…Hypertension is a widely recognized adverse effect of α‐agonist use in humans. It has been reported with PPA treatment in dogs at a much lower rate, but preexisting hypertension or comorbidities that predispose to hypertension such as kidney disease or hyperthyroidism are considered contraindications for its use . Reevaluation of blood pressure during treatment with PPA is recommended to monitor for hypertension, particularly because USMI patients are likely to be on lifelong treatment, often with dose escalation over time.…”
Section: Discussionmentioning
confidence: 99%
“…5 Phenylpropanolamine (PPA) a is approved for use in dogs for treatment of PUSMI, and is thought to exert its effects by stimulating alpha-adrenergic receptors along the urethra, bladder neck and urethral sphincter. 6 The use of PPA, however, has potential side effects which can be quite serious (e.g. emesis, hypertension, weight loss proteinuria).…”
mentioning
confidence: 99%
“…As a result of these potential side effects in humans and pets, PPA is no longer available without a prescription for animals; and due to the increased risk of hemorrhagic stroke is not available for human use in the United States. [6][7] It has also been withdrawn from the market in a number of other countries. 8 Estrogen supplementation represents the next most common treatment option; however, the side effects are significant and include induction of estrous, mammary gland enlargement and the formation of mammary tumors.…”
mentioning
confidence: 99%